{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:09:24Z","timestamp":1787879364291,"version":"build-2784847793"},"reference-count":61,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.dld.2010.12.014","type":"journal-article","created":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T09:57:22Z","timestamp":1298109442000},"page":"535-541","source":"Crossref","is-referenced-by-count":40,"title":["Validation of the Italian translation of the Inflammatory Bowel Disease Questionnaire"],"prefix":"10.1016","volume":"43","author":[{"given":"Rachele","family":"Ciccocioppo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Klersy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Valli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Boccaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venerina","family":"Imbesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Ardizzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele Bianchi","family":"Porro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino Roberto","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2010.12.014_bib0005","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2010.12.014_bib0010","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1185\/030079905X65457","article-title":"Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease","volume":"21","author":"Geboes","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.dld.2010.12.014_bib0015","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2036.2010.04380.x","article-title":"Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single center cohort","volume":"32","author":"Gies","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2010.12.014_bib0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ibd.21048","article-title":"World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010","volume":"16","author":"Bernstein","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0025","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/ibd.20353","article-title":"Population-based controlled study of social support, self-perceived stress, activity and work issue, and access to health care in Inflammatory Bowel Disease","volume":"14","author":"Rogala","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0030","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1023\/A:1020841601110","article-title":"Factors affecting health related quality of life of patients with inflammatory bowel disease","volume":"11","author":"Casellas","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.dld.2010.12.014_bib0035","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00042737-200510000-00006","article-title":"Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis","volume":"17","author":"Bernklev","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.12.014_bib0040","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/01.MIB.0000218762.61217.4a","article-title":"Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease","volume":"12","author":"Bernklev","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0045","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/gast.2002.31072","article-title":"A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease","volume":"122","author":"Sandborn","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.12.014_bib0050","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","article-title":"A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with ulcerative colitis","volume":"132","author":"D\u2019Haens","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.12.014_bib0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/00365529309098351","article-title":"Quality of Life\u2014rationale and methods for developing a disease-specific instrument for inflammatory bowel disease","volume":"199","author":"Irvine","year":"1993","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.dld.2010.12.014_bib0060","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0016-5085(94)90585-1","article-title":"Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group","volume":"106","author":"Irvine","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.12.014_bib0065","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00042737-200105000-00017","article-title":"Influence of inflammatory bowel disease on different dimensions of quality of life","volume":"13","author":"Casellas","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.12.014_bib0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.clinthera.2008.02.016","article-title":"Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease","volume":"30","author":"Reilly","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.dld.2010.12.014_bib0075","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0016-5085(89)80080-0","article-title":"A new measure of health status for clinical trials in inflammatory bowel disease","volume":"96","author":"Guyatt","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.12.014_bib0080","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ibd.21032","article-title":"Need for standardization in population-based quality of life studies: a review of the current literature","volume":"16","author":"Hoivik","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.dld.2010.12.014_bib0090","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0895-4356(98)00094-8","article-title":"The Italian SF-36 Health Survey: translation, validation and norming","volume":"51","author":"Apolone","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2010.12.014_bib0095","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0895-4356(98)00082-1","article-title":"Translating health status questionnaires and evaluating their quality: the IQOLA project approach. International quality of life assessment","volume":"51","author":"Bullinger","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2010.12.014_bib0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ibd.3780060103","article-title":"A simple classification of Crohn's disease: report of the working party for the World Congresses of Gastroenterology. Vienna 1998","volume":"6","author":"Gausche","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index, National Cooperative Crohn's Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2010.12.014_bib0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","article-title":"Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial","volume":"298","author":"Rachmilewitz","year":"1989","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2010.12.014_bib0115","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/gut.30.7.983","article-title":"Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d\u2019Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)","volume":"30","author":"Mary","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.dld.2010.12.014_bib0120","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0895-4356(98)00085-7","article-title":"Methods for testing data quality, scaling assumptions, and reliability: the IQOLA project approach. International quality of life assessment","volume":"51","author":"Ware","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2010.12.014_bib0125","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/00042737-199511000-00006","article-title":"Inflammatory Bowel Disease Questionnaire: cross-cultural adaptation and further validation","volume":"7","author":"de Boer","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.12.014_bib0130","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/003655298750026994","article-title":"The inflammatory bowel disease questionnaire: a valid and reliable measure in ulcerative colitis patients in the North East of England","volume":"33","author":"Han","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000007670","article-title":"Validation of the Spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease","volume":"60","author":"L\u00f3pez-Vivancos","year":"1999","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2010.12.014_bib0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0895-4356(99)00152-3","article-title":"The UK IBDQ\u2014A British version of the inflammatory bowel disease questionnaire. Development and validation","volume":"53","author":"Cheung","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2010.12.014_bib0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/00365520150218093","article-title":"Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis","volume":"36","author":"Hjortswang","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0150","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/003655202760373371","article-title":"Inflammatory Bowel South-Eastern Norway (IBSEN) Group of Gastroenterologists. Quality of life in patients with inflammatory bowel disease: translation, data quality, scaling assumptions, validity, reliability and sensitivity to change of the Norwegian version of IBDQ","volume":"37","author":"Bernklev","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0155","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1572-0241.2003.07518.x","article-title":"Improved validation of the Inflammatory Bowel Disease Questionnaire and development of a short form in Greek patients","volume":"98","author":"Vlachonikolis","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0160","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s00535-003-1220-x","article-title":"Reliability, validity, and responsiveness of the Japanese version of the Inflammatory Bowel Disease Questionnaire","volume":"38","author":"Hashimoto","year":"2003","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0165","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1080\/00365520500529488","article-title":"Evaluation of the Inflammatory Bowel Disease Questionnaire in Swedish patients with Crohn's disease","volume":"41","author":"Stjernman","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0170","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ibd.20128","article-title":"Validation of the Mainland Chinese Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease","volume":"13","author":"Ren","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0175","first-page":"439","article-title":"Quality of life in inflammatory bowel disease: psychometric evaluation of an IBDQ cross-culturally adapted version","volume":"17","author":"Verissimo","year":"2008","journal-title":"J Gastrointest Liver Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0180","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ibd.20301","article-title":"Quality of Life of patients with ulcerative colitis: past, present, and future","volume":"14","author":"Irvine","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0185","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/ibd.20556","article-title":"How does IBD affect quality of life?","volume":"14","author":"Clearfield","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.dld.2010.12.014_bib0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2036.17.s2.17.x","article-title":"Review article: Crohn's disease: monitoring disease activity","volume":"17","author":"Sostegni","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2010.12.014_bib0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ibd.3780060305","article-title":"Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group","volume":"6","author":"Irvine","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1572-0241.2000.01681.x","article-title":"Impact of surgery for Crohn's disease on health-related quality of life","volume":"95","author":"Casellas","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00054725-200207000-00001","article-title":"Infliximab improves quality of life in patients with Crohn's disease","volume":"8","author":"Lichtenstein","year":"2002","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0210","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/j.1572-0241.2003.07674.x","article-title":"The effects of infliximab maintenance therapy on health-related quality of life","volume":"98","author":"Feagan","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0215","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/ibd.20205","article-title":"Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years","volume":"13","author":"Casellas","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0220","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1111\/j.1572-0241.2007.01508.x","article-title":"Health-related quality of life during natalizumab maintenance therapy for Crohn's disease","volume":"102","author":"Feagan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0225","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1572-0241.2007.01094.x","article-title":"The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients","volume":"102","author":"Feagan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0230","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/j.1572-0241.2008.02175.x","article-title":"Effects of adalimumab maintenance therapy on Health-Related Quality of Life of patients with Crohn's disease: patient-reported outcomes of the CHARM Trial","volume":"103","author":"Loftus","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0235","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1365-2036.2008.03854.x","article-title":"The effect of mesalamine therapy on quality of life in patients with mildly to moderately active ulcerative colitis","volume":"28","author":"Irvine","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2010.12.014_bib0240","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00384-007-0395-7","article-title":"CDP870 Crohn's Disease Study Group. Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFalpha, improves health-related quality of life in patients with moderate to severe Crohn's disease","volume":"23","author":"Rutgeerts","year":"2008","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0245","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-230X-10-26","article-title":"The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients","volume":"10","author":"Bastida","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0250","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/gut.2009.179994","article-title":"A randomized placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease","volume":"59","author":"Dotan","year":"2010","journal-title":"Gut"},{"issue":"Suppl.","key":"10.1016\/j.dld.2010.12.014_bib0255","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3109\/00365529509107776","article-title":"Quality of Life in inflammatory bowel disease: biases and other factors affecting scores","volume":"208","author":"Irvine","year":"1995","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0260","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1023\/B:QURE.0000021701.28467.57","article-title":"A comparison of the discriminatory power of the Inflammatory Bowel Disease Questionnaire and the SF-36 in people with ulcerative colitis","volume":"13","author":"McColl","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1016\/j.dld.2010.12.014_bib0265","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s11136-010-9650-4","article-title":"Health-related quality of life in inflammatory bowel disease measured with the generic 15D instrument","volume":"19","author":"Haapam\u00e4ki","year":"2010","journal-title":"Qual Life Res"},{"key":"10.1016\/j.dld.2010.12.014_bib0270","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/01.mib.0000234134.35713.d2","article-title":"Health-related quality of life correlates with clinical and endoscopic activity indexes but not with demographic features in patients with ulcerative colitis","volume":"12","author":"Zahn","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0275","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.MIB.0000217768.75519.32","article-title":"Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's disease","volume":"12","author":"Hlavaty","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0280","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1111\/j.1572-0241.2005.00360.x","article-title":"Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life","volume":"100","author":"Casellas","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2010.12.014_bib0285","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/ibd.21215","article-title":"Preliminary evidence supporting a framework of psychological adjustment to inflammatory bowel disease","volume":"16","author":"Kiebles","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0290","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ibd.20583","article-title":"Adjustment to inflammatory bowel disease: the relative influence of illness perceptions and coping","volume":"15","author":"Dorrian","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2010.12.014_bib0295","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00042737-200309000-00012","article-title":"The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis","volume":"15","author":"Hjortswang","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2010.12.014_bib0300","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s11136-009-9514-y","article-title":"Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease","volume":"18","author":"Haapam\u00e4ki","year":"2009","journal-title":"Qual Life Res"},{"key":"10.1016\/j.dld.2010.12.014_bib0305","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00054725-200405000-00014","article-title":"The inflammatory bowel disease questionnaire: a review of its national validation studies","volume":"10","author":"Pallis","year":"2004","journal-title":"Inflamm Bowel Dis"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865811000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865811000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T17:22:09Z","timestamp":1560014529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865811000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1590865811000119"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2010.12.014","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}